THE EVIDENCE FOR 20 MG A DAY OF FLUOXETINE AS THE OPTIMAL DOSE IN THE TREATMENT OF DEPRESSION

被引：92

作者：

ALTAMURA, AC

MONTGOMERY, SA

WERNICKE, JF

机构：

[1] ST MARYS HOSP, SCH MED, DEPT PSYCHIAT, LONDON W2 1NY, ENGLAND

[2] ELI LILLY & CO, INDIANAPOLIS, IN 46285 USA

来源：

关键词：

D O I：

10.1192/S0007125000297377

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

引用

页码：109 / 112

页数：4

共 10 条

[1] DORNSEIF BE, 1988, 1988 NEW CLIN DRUG E
[2] FABRE LF, 1987, J CLIN PSYCHIAT, V48, P406
[3] FEIGHNER JP, 1985, J CLIN PSYCHIAT, V46, P20
[4] A DOUBLE-BLIND COMPARISON OF ZIMELIDINE AND AMITRIPTYLINE IN ENDOGENOUS-DEPRESSION
MONTGOMERY, SA
MCAULEY, R
RANI, SJ
ROY, D
MONTGOMERY, DB
[J]. ACTA PSYCHIATRICA SCANDINAVICA, 1981, 63 : 314 - 327
[5] MONTGOMERY SA, 1986, 15TH CINP C
[6] STARK P, 1985, J CLIN PSYCHIAT, V46, P7
[7] 5-HT REUPTAKE INHIBITORS PLUS TRYPTOPHAN IN ENDOGENOUS-DEPRESSION
WALINDER, J
CARLSSON, A
PERSSON, R
[J]. ACTA PSYCHIATRICA SCANDINAVICA, 1981, 63 : 179 - 190
[8] WERNICKE JF, 1988, PSYCHOPHARMACOL BULL, V24, P183
[9] WERNICKE JF, 1987, PSYCHOPHARMACOL BULL, V23, P164
[10] WOOD KM, 1982, BRIT J CLIN PRACTI S, V19, P42